跳至主要内容
临床试验/ITMCTR2200006378
ITMCTR2200006378招募中1 期

Study on the clinical and mechanism of ''Tiaoshen liqi'' acupuncture in the treatment of mild depression

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria for mild depression of the International Classification of Diseases 10th revision (ICD-10).
  • 2. Aged between 18 and 70 years.
  • 3. The score of HDRS-24: 20 =HDRS= 26.
  • 4. Patients who have not participated in other clinical trials within the last 1 month.
  • 5. Patients who have not received treatment such as acupuncture and medication for depression within the last 1 week.
  • 6. Patients who do not have aphasia or mental retardation, can understand the content of the scale and cooperate with 4 weeks of acupuncture treatment and follow-up for 3 months and sign an informed consent form.

排除标准

  • 1. Meet the diagnostic criteria for schizophrenia, bipolar depression or other psychotic disorders with suicidal tendencies.
  • 2. Patients with severe heart, liver, kidney and other systemic diseases.
  • 3. Pregnant or lactating women.
  • 4. Patients who cannot tolerate needling, or who have skin infection or breakdown at the site of needling, coagulation disorders, easy to get dizzy, or extreme weakness.
  • 5. Patients who have participated in other clinical trials within 1 month prior to the start of this study.
  • 6. Patients who have taken antidepressants or received acupuncture treatment for depression within 1 week prior to the start of this study.
  • 7. Patients with severe cognitive and consciousness impairment that affects communication and unwillingness to cooperate, and who have not signed the informed consent form.

研究者

发起方
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

相似试验